A study on the role of Tai Chi training in improving type 2 diabetes mellitus.

Six months of Tai Chi training significantly reduced body composition measures in T2DM patients.

• 36 patients with T2DM underwent 6 months of Tai Chi training
• Significant reductions were observed in body weight, BMI, waist circumference, and body fat percentage (p < 0.05)
• Lean body mass increased significantly (p < 0.05)
• Body composition was measured as part of a broader assessment including biochemical indicators

Tai Chi training significantly improved glycemic control and lipid markers in T2DM patients.

• Fasting blood glucose, glycated hemoglobin, and insulin resistance index (HOMA-IR) decreased significantly (p < 0.01)
• Total cholesterol levels also decreased significantly (p < 0.01)
• Measurements were taken before and after the 6-month intervention period
• Biochemical indicators were assessed as part of the study's outcome measures

Tai Chi training significantly reduced pro-inflammatory markers and increased the anti-inflammatory factor IL-10.

• CRP, TNF-α, IL-6, IL-1β, and IL-8 levels decreased significantly (p < 0.01)
• The anti-inflammatory factor IL-10 increased significantly (p < 0.01)
• Serum inflammatory factors were measured as part of the study's outcome measures
• Changes in inflammatory markers were observed across 36 T2DM patients after 6 months

Tai Chi training significantly increased gut microbiota richness and diversity in T2DM patients.

• The Chao1 and Shannon indices increased significantly (p < 0.05)
• Gut microbiota was assessed using 16S rRNA sequencing
• The abundance of beneficial bacteria increased significantly, while the abundance of harmful bacteria decreased significantly (p < 0.01)
• Gut microbiota changes were measured in 36 T2DM patients after 6 months of training

Tai Chi training significantly improved intestinal mucosal barrier function markers in T2DM patients.

• D-lactate and zonulin decreased significantly (p < 0.01), indicating improved intestinal barrier integrity
• Milk fat globule-EGF factor 8 (MFG-E8) increased significantly (p < 0.01)
• These markers of intestinal mucosal barrier function were measured before and after the 6-month intervention
• Intestinal mucosal barrier function was assessed alongside gut microbiota and inflammatory markers in 36 T2DM patients